Theocharis Panaretakis

Title: The Innovations of Theocharis Panaretakis

Introduction

Theocharis Panaretakis is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on understanding the susceptibility of tumor cells to various cancer therapies.

Latest Patents

Theocharis Panaretakis holds a patent titled "Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment." This invention relates to a method for determining the susceptibility of a patient's tumor cell to cancer treatment. The method involves the detection or measurement of calreticulin, KDEL receptor, and/or ERp57 on the surface of tumor cells. He has 1 patent to his name.

Career Highlights

Throughout his career, Panaretakis has worked with prestigious institutions such as the Gustave Roussy Institute and the National Institute of Health and Medical Research. His research has contributed to advancements in cancer treatment methodologies and patient care.

Collaborations

He has collaborated with prominent researchers in the field, including Guido Kroemer and Laurence Zitvogel. Their joint efforts have furthered the understanding of cancer biology and treatment efficacy.

Conclusion

Theocharis Panaretakis is a distinguished inventor whose work has the potential to impact cancer treatment significantly. His innovative approaches and collaborations highlight the importance of research in improving patient outcomes.